Periscope Capital’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Periscope Capital’s Portfolio APGNW Stock Details APGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-142,340	Closed	-$16K	–	1172
2022 Q2	$16K	Hold	142,340	–	–	﹤0.01%	1018
2022 Q1	$60K	Hold	142,340	–	–	﹤0.01%	902
2021 Q4	$61K	Hold	142,340	–	–	﹤0.01%	899
2021 Q3	$94K	Sell	142,340 -200	-0.1%	-$192	﹤0.01%	784
2021 Q2	$217K	Sell	142,540 -4,885	-3%	-$7.99K	0.01%	592
2021 Q1	$250K	Buy	+147,425	New	+$299K	0.01%	449

Other funds holding APGNW

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

YCM

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Skaana Management Brooklyn, New York $296M AUM 65.1% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Periscope Capital's APGNW Position: Q3 2022 in Review

Periscope Capital sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2022, closing a stake of 142,340 shares — an estimated $16K sold.

Periscope Capital first reported a position in APGNW in Q1 2021 and held it in 6 quarters. The position peaked at $250K in Q1 2021. 16 funds tracked by Wall St. Rank hold APGNW as of Q3 2022.

Periscope Capital reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2022 after selling out during the quarter.
Periscope Capital sold 142,340 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2022, an estimated $16K.
Periscope Capital first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q1 2021 and held it in 6 quarters.
Periscope Capital's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $250K in Q1 2021.
16 funds tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2022.

Based on Periscope Capital's 13F filing for Q3 2022, filed 8 Nov 2022.